Clinical Trial Update: A Study Comparing MRG004A Plus Best Supportive Care Versus Placebo and Best Supportive Care in the Treatment of Patients With Advanced Pancreatic Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating MRG004A plus best supportive care versus placebo plus best supportive care in advanced pancreatic cancer is currently not yet recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• MRG004A

Snippet

Sponsor: Shanghai Miracogen Inc. | Conditions: Advanced Pancreatic Cancer | Phase 3 | Status: NOT_YET_RECRUITING